TickerKhojComparison · NSE · data 2026-11-02
Anuh Pharma Limited vs Lincoln Pharmaceuticals Ltd
In plain words
Size: Lincoln Pharmaceuticals Ltd is about 1.2 times the market value of Anuh Pharma Limited.
Valuation (P/E): Anuh Pharma Limited 15.4 vs Lincoln Pharmaceuticals Ltd 10.5.
Profit growth over 3 years: Lincoln Pharmaceuticals Ltd 6.4% a year vs Anuh Pharma Limited 4.3% a year.
Debt to equity: Lincoln Pharmaceuticals Ltd 0.01 vs Anuh Pharma Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ANUHPHR | LINCOLN | |
|---|---|---|
| Price | ₹85.62 | ₹506.15 |
| Market cap | ₹873 cr | ₹1,005 cr |
| P/E | 15.4 | 10.5 |
| P/B | — | — |
| ROE | 12.1% | 12.3% |
| ROCE | 17.0% | 10.9% |
| Debt / equity | 0 | 0.01 |
| Operating margin | 6.9% | 12.4% |
| Dividend yield | 1.72% | 0.36% |
| Sales growth, 3 years (yearly) | 13.5% | 9.4% |
| Profit growth, 3 years (yearly) | 4.3% | 6.4% |
| 1-year return | -2.9% | -4.9% |
| Revenue, last 12 months | ₹779 cr | ₹694 cr |
| Net profit, last 12 months | ₹44 cr | ₹96 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹11 cr | ₹20 cr |
| Quarter profit vs a year earlier | +47.3% | +2.3% |
| Promoter holding | 71.80% | 49.78% |
| Health check | Strong (7.5/10) | Strong (6.6/10) |
Common questions
Which has a higher P/E, Anuh Pharma Limited or Lincoln Pharmaceuticals Ltd?
Anuh Pharma Limited trades at the higher P/E (15.4 against 10.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Lincoln Pharmaceuticals Ltd (12.3% against 12.1%).
Which carries more debt?
Lincoln Pharmaceuticals Ltd has the higher debt-to-equity ratio (0.01 against 0).